PharmEasy

Get the latest news & updates on PharmEasy in India’s startup ecosystem. Stay ahead with the latest news, funding & acquisition alerts, financials and business updates about PharmEasy

PharmEasy Raises INR 1,804 Cr At A 90% Valuation Cut

PharmEasy Rights Issue: Epharmacy Raises INR 1,804 Cr At A 90% Valuati...

Barely a month after the Competition Commission of India (CCI) greenlit PharmEasy’s…
CCI Clears Ranjan Pai, 360 One’s Stake Acquisition In PharmEasy

PharmEasy Rights Issue: CCI Clears Ranjan Pai, 360 One’s Stake Acquisi...

The Competition Commission of India (CCI) on Tuesday (March 26) approved the…
PharmEasy Rights Issue: Goldman Sachs, Prosus, Temasek Gets CCI Nod To Acquire Stake

PharmEasy Rights Issue: Goldman Sachs, Prosus, Temasek Get CCI Nod To ...

Close on the heels of PharmEasy’s ‘oversubscribed’ rights…
PharmEasy’s Sales Cross INR 6,000 Cr Mark In FY23, Posts INR 5,211 Cr Loss

PharmEasy’s Sales Cross INR 6,000 Cr Mark In FY23, Posts INR 5,211 Cr ...

Epharmacy startup PharmEasy saw its operating revenue cross…
PharmEasy’s Sales Cross INR 6,000 Cr Mark In FY23, Posts INR 5,211 Cr Loss

PharmEasy Biggest Underperformer In Prosus’ India Portfolio In H1 FY24...

Online pharmacy major PharmEasy was the biggest underperformer…
Exclusive: PharmEasy Names Yatharth Bhargova As Its New CFO

Exclusive: PharmEasy Names Yatharth Bhargova As Its New CFO

Healthtech unicorn PharmEasy has named Yatharth Bhargova as…
PharmEasy's INR 3,500 Cr Rights Issue Oversubscribed, Claims Cofounder Dhaval Shah

PharmEasy’s INR 3,500 Cr Rights Issue Oversubscribed, Claims Cofounder...

Healthtech unicorn PharmEasy’s recently conducted INR 3,500 Cr…
PharmEasy’s Sales Cross INR 6,000 Cr Mark In FY23, Posts INR 5,211 Cr Loss

PharmEasy Plans To Raise INR 3,500 Cr Through Right Issue

Amid serious financial troubles, healthtech unicorn PharmEasy will…

Debt-Laden PharmEasy To Raise INR 2,000 Cr-INR 3,000 Cr Via Right Issu...

API Holdings, the parent entity of debt-laden PharmEasy,…
PharmEasy Board Okays Plan To Raise Additional Capital, Ball In Investors’ Court

PharmEasy Board Okays Plan To Raise Additional Capital, Ball In Invest...

Caught in the middle of multiple financial troubles,…
PharmEasy’s Sales Cross INR 6,000 Cr Mark In FY23, Posts INR 5,211 Cr Loss

Debt-Laden PharmEasy To Raise INR 2,400 Cr Through Right Issue At A 90...

Amid serious financial troubles, healthtech startup PharmEasy has…
[gravityform id="103" title="true" ajax="true"]

My inc42

Your Personalised Access To India's Tech & Startup Economy

Congratulations!

You've just followed your first industry and unlocked your personalised experience with My Inc42.

AgriTech
CleanTech
Consumer Internet
Ecommerce
EdTech
Electric Vehicles
EnterpriseTech
FinTech
HealthTech
Logistics
Retail
Startup Ecosystem
TravelTech